NCT06607588Recruiting
Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique
Selection of Resistant Mutations to Dolutegravir and Associated Drugs in PLWH Treated in Clinical Practice in Chokwé, Mozambique
Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 17 Sept 2024
- Start date
- 25 Oct 2024
- Primary completion date
- Apr 2026
- Lead sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- Diseases
- HIV
- NCT number
- NCT06607588
What you commit to
- Study type: Observational
- Planned participants: 200
- From 25 Oct 2024 to the primary completion date, Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with active opportunistic diseases.
Age
- Patients \<18 years of age.
Other
- Under the first line regime other than TLD.
- Patients with active neoplastic processes.
- Patients unable to give informed consent.
Who the study is looking for
- Patients able to understand and sign the informed consent form.
- Documented HIV-1 infection.
- Under the first line TLD for at least 6 months.
- At least 3 months follow-up with CV \>200c/ml.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Carmelo Coordinator of this site? Confirm its status | Chokwé | Mozambique | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.